Role of high dose corticosteroids and visual outcome in cases of traumatic optic neuropathy with delayed presentation in a tertiary eye care centre
Abstract
Background: Optic nerve injuries occur in the setting of head injury which is often a consequence of road traffic accidents or falls. Traumatic optic neuropathy (TON) is a potentially blinding complication of head and orbital trauma. Different treatment approaches like different dosages of steroids, surgical decompression and observation alone have been suggested but there is no standardized protocol till date.
Object: To study the clinical profile, risk factors, visual outcome in a series of forty five patients of Traumatic Optic Neuropathy (TON) after medical management at our tertiary centre.
Methods: Forty five patients reported to outpatient department from January 2018 to June 2019 who have a history of trauma were studied prospectively.After relevant and detailed ocular examination, Intravenous methyl prednisolone 1 gram for 5days and thenoral prednisolone 1 mg/kg in tapering doses for two weeks was administered in all patients irrespective of duration of presentation to the hospital after trauma.
Results: The age group involved was predominantly 16 to 45years (80%) with a mean age of 35.31 years. Range of follow up was seen from 5days to 5 months. Males (91%) were outnumbered. Road traffic accidents (73.33%) were found to be the most common cause for TON in our series. Of 45, 10 patients were lost to follow up, rest 35 patients who have been followed steroid regime, 18 (51.43%) showed visual improvement (12 patients had >/=2 line improvement, rest 06 patient had one line improvement). 17(48.57%) patients did not show any improvement. 08 patients were same (no perception of light) till the final follow up.
Conclusion: IV methyl prednisolone along with oral steroids as proposed by ONTT has been found effective in our case series of TON even in patients who have very low initial visualacuity and who presented late even after 24 hours of injury till the irreversible damage to optic nerve.No major side effects have been encountered with this steroid regimen. High dose steroid has proven its role in traumatic optic neuropathy.
Downloads
References
2. Steinsapir KD, Goldberg RA. Traumatic optic neuropathy.Surv Ophthalmol. 1994; 38(6):487-518. DOI: https: // doi.org/ 10.1016/ 0039-6257(94)90145-7
3. Carta A, Ferrigno L, Salvo M, Bianchi-Marzoli S, Boschi A, Carta F. Visual prognosis after indirect traumatic optic neuropathy. J Neurol Neurosurg Psychiatry. 2003;74(2): 246-8.DOI:10.1136/jnnp. 74. 2.246
4. Kovacić M, Gracner T, Gracner B. Indirect traumatic optic neuropathy--two case report. Coll Antropol. 2001;25 Suppl:57-61.
5. Sadeghi-Tari A, Lashay AR, Tabassi A. Visual outcome of traumatic opticneuropathy in patients treated with intravenous megadose of steroids.Acta Medica Iranica 2005;43(2):110-114.
6. Li KK, Teknos TN, Lai A, Lauretano AM, Joseph MP. Traumatic optic neuropathy: result in 45 consecutive surgically treated patients. Otolaryngol Head Neck Surg. 1999;120(1):5-11.DOI:10.1016 /S0194 -5998(99)70362-1
7. Lee V, Ford RL, Xing W, Bunce C, Foot B. Surveil-lance of traumatic optic neuropathy in the UK. Eye (Lond). 2010;24(2):240-50. DOI: 10.1038/eye. 2009. 79
8. Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthal-mology. 1999;106(7):1268-77. DOI: https://doi. org/10. 1016/S0161-6420(99)00707-1
9. Chou PI, Sadun AA, Chen YC, Su WY, Lin SZ, Lee CC. Clinical experiences in the management of traumatic optic neuropathy. Neuro-Ophthalmology. 1996;16(6):325–336.DOI:https://doi.org/10.3109/01 658 109609044636
10. Davidson M. The indirect traumatic optic atrophies. Am J Ophthalmol;1938;21(1):7
11. Pirouzmand F. Epidemiological trends of traumatic optic nerve injuries in the largest Canadian adult trauma center. J Craniofac Surg. 2012;23(2):516-20. DOI: 10. 1097/SCS.0b013e31824cd4a7.
12. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury.Results of the Second National Acute Spinal Cord Injury Study.N Engl J Med. 1990; 322 (20):1405-11.DOI:10.1056/ NEJM 199005173222001
13. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazadmesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277(20):1597-604.
14. Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ. Treatment of traumatic optic neuropathy with cortico-steroids. Am J Ophthalmol. 1990;110(6): 665-9. DOI: 10. 1016/s0002-9394(14)77065-5
15. Edwards P, Arango M, Balica L, Cottingham R, El-Sayed H, Farrell B, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365(9475):1957-9. DOI:10.1016/ S0140-6736(05)66552-X
16. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2011; 19 (1):CD006032. DOI: 10.1002/14651858. CD006032. pub3.
17. Volpe NJ, Levin LA. How should patients with indirect traumatic optic neuropathy be treated? J Neuroophthalmol. 2011;31(2):169-74. DOI: 10.1097/ WNO. 0b013e31821c9b11.
18. Wang BH, Robertson BC, Girotto JA, Liem A, Miller NR, Iliff N, et al. Traumatic optic neuropathy: a review of 61 patients. Plast Reconstr Surg. 2001;107 (7):1655-64.DOI:10.1097/00006534-200106000-00003
19. Cook MW, Levin LA, Joseph MP, Pinczower EF. Traumatic optic neuropathy.A meta-analysis.Arch Otolaryngol Head Neck Surg. 1996;122(4):389-92. DOI: 10.1001/archotol.1996.01890160031006
20. Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ. Treatment of traumatic optic neuropathy with cortico-steroids. Am J Ophthalmol. 1990;110(6):665-9.DOI: 10.1016/s0002-9394(14)77065-5
21.Yu-Wai-Man P, Griffiths PG. Surgery for traumatic optic neuropathy.CochraneDatabaseSyst Rev. 2005;19 (4):CD005024.DOI:10.1002/14651858.CD005024.pub2
22. Hall ED. The neuroprotective pharmacology of methylprednisolone.J Neurosurg. 1992;76(1):13-22. DOI: 10.3171/jns.1992.76.1.0013
Copyright (c) 2019 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.